Data / Drug companies / Chlorpheniramine maleate, phenylephrine hcl
Chlorpheniramine maleate, phenylephrine hcl: 7 companies and 7 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Chlorpheniramine maleate, phenylephrine hcl is listed in the FDA National Drug Code Directory by 7 companies, with 7 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on September 1, 2021.
The request: Get every company that lists chlorpheniramine maleate, phenylephrine hcl in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 7
- Products
- 7
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Giltuss D Allergy and Congestion, Sinus and Allergy Relief Pe, Cold and Allergy, Sinus Pe Plus Allergy Maximum Strength, Suphedrine Pe Sinus Plus Allergy, Sinus Pe and Allergy, Sinus Plus Allergy Pe Maximum Strength
- openFDA record search
- api.fda.gov
Companies that list chlorpheniramine maleate, phenylephrine hcl
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Army and Air Force Exchange Service | 1 | tablet | Over the counter monograph drugs | June 9, 2005 |
| CVS Pharmacy | 1 | tablet | Over the counter monograph drugs | June 9, 2005 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | tablet | Over the counter monograph drugs | June 1, 2019 |
| Gil Pharmaceutical Corp | 1 | tablet | Over the counter monograph drugs | November 17, 2016 |
| Topco Associates LLC | 1 | tablet | Over the counter monograph drugs | July 2, 2021 |
| United Natural Foods, Inc. DBA Unfi | 1 | tablet | Over the counter monograph drugs | June 9, 2005 |
| Walmart Inc. | 1 | tablet | Over the counter monograph drugs | September 1, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 7 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 7 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Histamine-1 Receptor Antagonist | 7 |
| alpha-1 Adrenergic Agonist | 7 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.